Clinical trial

SPECS: Safe Pediatric Euglycemia in Cardiac Surgery

NCT00443599 · Boston Children's Hospital, Other · Completed

Key facts

NCT number NCT00443599
Title SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
Official title Maintaining Normal Blood Sugar Levels in Children Undergoing Heart Surgery to Reduce the Risk of Infections and Improve Recovery (The SPECS Study)
Acronym SPECS
Lead sponsor Boston Children's Hospital, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH
Status Completed
Study type Interventional
Conditions Heart Defects, Congenital, Hyperglycemia
Intervention type Drug, Other
Interventions Insulin, Usual Care
Enrollment 989
Start date Nov 1, 2006
Primary completion Jun 1, 2012
Completion Jan 1, 2014
First posted Mar 6, 2007
Last update posted Jul 25, 2022
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies